SCHEMBL321167

SCHEMBL321167

NCC1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL83314 1.00
SCHEMBL82149 1.00
Hydrochloric Acid SCHEMBL9993578 0.97
Hydrochloric Acid SCHEMBL11302777 0.97
Hydrochloric Acid SCHEMBL29202607 0.97
Hydrochloric Acid SCHEMBL12076441 0.97
Hydrochloric Acid SCHEMBL12076346 0.97
SCHEMBL10582198 0.97
Hydrochloric Acid SCHEMBL4741693 0.97
SCHEMBL82024 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117969421-A Universal sensor and method for identifying absolute configuration and optical purity of beta-chiral primary amine 中国医学科学院药物研究所 2024-05-03 CN claimed
CN-111574420-B Preparation method of aminopyrrolidine 北京石油化工学院 2022-09-20 CN claimed
CN-111574420-A Preparation method of aminopyrrolidine 北京石油化工学院 2020-08-25 CN claimed
US-20200115339-A1 EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF Basilea Pharmaceutica International AG (CH) 2020-04-16 US claimed
US-10464896-B2 Efflux-pump inhibitors and therapeutic uses thereof Basilea Pharmaceutica International AG (CH) 2019-11-05 US claimed
US-20180179158-A1 EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF Basilea Pharmaceutica International AG (CH) 2018-06-28 US claimed
EP-3307725-A1 EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF Basilea Pharmaceutica International AG (CH) 2018-04-18 EP claimed
WO-2017093157-A1 PIPERIDINE, PYRROLIDINE AND 2-OXO-1,3-OXAZINANE DERIVATIVES AS INHIBITORS OF BACTERIAL EFFLUX-PUMPS FOR THE TREATMENT OF MICROBIAL INFECTIONS BASILEA PHARMACEUTICA AG (CH) 2017-06-08 WO claimed
WO-2016198691-A1 EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF BASILEA PHARMACEUTICA AG (CH) 2016-12-15 WO claimed
CN-103097425-B Process for preparing polyol mixtures BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-10-07 CN claimed
EP-1017358-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2000-07-12 EP claimed
US-6056973-A Therapeutic liposome composition and method of preparation SEQUUS PHARMACEUTICALS, INC. (US) 2000-05-02 US claimed
US-5939458-A APPLYING AN INHIBITOR OF AMINOACYL-TRNA SYNTHETASE TO THE SKIN GILLETTE COMPANY, THE 1999-08-17 US claimed
WO-1999015136-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 1999-04-01 WO claimed
EP-0692470-A1 Process for the preparation of optically active 1-substituted-2-(aminomethyl)pyrrolidine derivatives Degussa Aktiengesellschaft (DE) 1996-01-17 EP claimed
EP-0539281-A1 New naphthamides, process for their preparation and their application in the therapeutical field INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1993-04-28 EP claimed
US-4950766-A Preparation of benzamides useful as antiemetic agents ERBAMONT, INC. (US) 1990-08-21 US claimed
US-4948784-A ANTICARCINOGENIC AND-TUMOR AGENTS; WATER-SOLUBEL MACROMOLICULAR COMPLEXES; SIDE EFFECT REDUCTION KURARAY COMPANY, LTD. (JP) 1990-08-14 US claimed
EP-0314483-A1 Preparation of benzamides ERBAMONT, INC. (US) 1989-05-03 EP claimed
CN-86106163-A New henzodiozepanne and synthetic method thereof and the application on therapeutics 1987-04-08 CN claimed